Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITAC: Vitamin C and Zinc in Enterocutaneous Fistulas
NCT06009744Recruiting
- Sponsor
- Hospital Juárez de México
- Start
- Aug 2023
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ascorbic acid and zinc in enterocutaneous fistula (ECF) (2 arms), sponsored by Hospital Juárez de México. Primary endpoints: Fistula closure at 30 days and Recurrence of fistula at 30 days. Started Aug 2023; status: recruiting.
02
Drugs
ascorbic acidzinc
03
Conditions
enterocutaneous fistula (ECF)
Beyond the preview
Go deeper on NCT06009744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06009744.